Variable |
Yes |
No |
P |
Total |
Median TTP |
Total |
Median TTP |
N |
(%) |
Hours |
(range) |
N |
(%) |
Hours |
(range) |
| Characteristics |
|
|
|
|
|
|
|
|
|
| Age > 60 years |
117 |
(71.3) |
13.3 |
(3.6-95.2) |
50 |
(29.9) |
14.5 |
(7.3-65.1) |
0.256 |
| Male |
100 |
(59.9) |
14.1 |
(3.6-95.2) |
67 |
(40.1) |
12.6 |
(4.4-69.9) |
0.074 |
| Charlson score ≥5 |
123 |
(73.7) |
13.6 |
(3.6-95.2) |
44 |
(26.3) |
13.2 |
(7.9-52.6) |
0.740 |
| MRSA |
55 |
(32.9) |
13.5 |
(7.9-81.5) |
112 |
(67.1) |
13.5 |
(3.6-95.2) |
0.934 |
| Community-acquired |
72 |
(43.1) |
12.4 |
(7.2-69.9) |
95 |
(56.9) |
12.4 |
(7.2-69.9) |
0.032 |
| Attributable mortality |
46 |
(27.5) |
13.2 |
(3.6-82.0) |
117 |
(70.1) |
13.6 |
(4.4-95.2) |
0.558 |
| Comorbidities |
|
|
|
|
|
|
|
|
|
| Cardiac insufficiency |
92 |
(55.1) |
13.2 |
(3.6-74.8) |
75 |
(44.9) |
14.4 |
(7.2-95.2) |
0.053 |
| Peripheral arterial disease |
18 |
(10.8) |
13.2 |
(4.4-28.0) |
149 |
(89.2) |
13.6 |
(3.6-95.2) |
0.541 |
| Diabetes |
50 |
(29.9) |
12.4 |
(7.9-65.2) |
117 |
(70.1) |
13.8 |
(3.6-95.2) |
0.156 |
| COPD |
50 |
(29.9) |
14.1 |
(3.6-95.2) |
117 |
(70.1) |
12.8 |
(4.4-81.5) |
0.040 |
| Prothesis |
43 |
(25.7) |
15.4 |
(3.6-81.9) |
124 |
(74.3) |
13.2 |
(7.0-95.2) |
0.222 |
| Stroke |
67 |
(40.1) |
15.4 |
(8.2-81.9) |
100 |
(59.9) |
12.9 |
(3.6-95.2) |
0.016 |
| Drug user |
8 |
(4.9) |
21.7 |
(10.2-38.4) |
159 |
(95.2) |
13.3 |
(3.6-95.2) |
0.018 |
| Criteria of severity |
|
|
|
|
|
|
|
|
|
| Complicated bacteremia |
32 |
(19.2) |
12.4 |
(7.2-38.4) |
135 |
(80.8) |
13.8 |
(3.6-95.2) |
0.088 |
| Persistent bacteremia |
15 |
(9.0) |
11.6 |
(4.4-18.5) |
152 |
(91.0) |
13.8 |
(3.6-95.2) |
0.010 |
| Intensive care unit stay |
51 |
(30.5) |
13.0 |
(3.6-52.6) |
116 |
(69.5) |
13.6 |
(7.0-95.2) |
0.074 |
| Prolonged hospitalization |
103 |
(61.7) |
14.0 |
(3.6-95.2) |
64 |
(38.3) |
12.7 |
(7.2-69.9) |
0.478 |
| Source of bacteremia |
|
|
|
|
|
|
|
|
|
| Primary (a) |
22 |
(13.2) |
13.0 |
(4.4-23.2) |
145 |
(86.8) |
13.7 |
(4.4-23.2) |
0.435 |
| Primary related to catheter (b) |
36 |
(21.6) |
11.6 |
(3.6-95.2) |
131 |
(78.4) |
13.9 |
(4.4-81.9) |
0.019 |
| Secondary endovascular (c) |
25 |
(15.0) |
12.4 |
(7.2-32.7) |
142 |
(85.0) |
13.8 |
(3.6-95.2) |
0.037 |
| Endocarditis |
18 |
(10.8) |
11.0 |
(7.2-32.7) |
149 |
(89.2) |
13.8 |
(3.6-95.2) |
0.006 |
| Central (a+b+c) |
83 |
(49.7) |
12.2 |
(3.6-95.2) |
84 |
(50.3) |
15.5 |
(7.0-81.9) |
<0.001 |
|
